XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.3
INCOME TAXES (Notes)
9 Months Ended
Sep. 30, 2024
Income Tax Contingency [Line Items]  
Income Tax Disclosure [Text Block] INCOME TAXES
The Company’s effective tax rate was (91)% and 139% for the three and nine months ended September 30, 2024, respectively, and 43% and (47)% for the three and nine months ended September 30, 2023, respectively. The following items caused the effective rate to differ from the statutory rate:

Tax expense of $0.1 million and $2.0 million during the three and nine months ended September 30, 2024, respectively, and tax benefits of $0.4 million during the nine months ended September 30, 2023, from the tax impacts of share-based compensation awards.
Tax expense of $0.2 million during the nine months ended September 30, 2024, from state taxes related to research and development expenditures.
Tax benefits of $0.4 million during the nine months ended September 30, 2023, from research tax credits.
Tax expense of $0.1 million during the three months ended September 30, 2023, from deduction limitations on executive compensation.
Tax expense of $0.1 million during the three months ended September 30, 2023, from a valuation allowance related to the impairment of an investment.